Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
110.20
+0.50 (0.46%)
Jan 21, 2026, 2:35 PM AST

TADAWUL:4016 Ratios and Metrics

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2,1942,436----
Enterprise Value
2,2372,496----
Last Close Price
109.70119.61----
PE Ratio
22.5530.51----
Forward PE
19.8924.86----
PS Ratio
4.786.18----
PB Ratio
5.916.62----
P/TBV Ratio
7.047.67----
P/FCF Ratio
26.10100.97----
P/OCF Ratio
21.7669.02----
EV/Sales Ratio
4.876.33----
EV/EBITDA Ratio
18.8125.19----
EV/EBIT Ratio
20.8827.95----
EV/FCF Ratio
26.61103.45----
Debt / Equity Ratio
0.170.180.200.300.330.25
Debt / EBITDA Ratio
0.520.660.731.111.050.72
Debt / FCF Ratio
0.742.710.861.443.445.49
Asset Turnover
0.870.800.760.700.73-
Inventory Turnover
1.561.681.441.371.45-
Quick Ratio
1.741.851.491.361.591.52
Current Ratio
2.652.652.362.222.302.66
Return on Equity (ROE)
27.90%23.67%22.44%21.72%25.52%-
Return on Assets (ROA)
12.64%11.39%10.83%10.10%12.09%-
Return on Invested Capital (ROIC)
16.07%13.91%13.21%12.06%14.23%-
Return on Capital Employed (ROCE)
25.40%22.70%23.40%22.30%25.40%28.20%
Earnings Yield
4.43%3.28%----
FCF Yield
3.83%0.99%----
Dividend Yield
2.28%1.67%----
Payout Ratio
48.29%18.79%54.69%61.14%56.12%49.80%
Total Shareholder Return
2.24%1.67%----
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.